Little evidence that insect bite remedies work
There is little evidence that over the counter remedies for simple insect bites actually work, and in most cases, no treatment at all will suffice, concludes an evidence review in the April Drug and Therapeutics Bulletin (DTB).
In the UK, midges, mosquitoes, flies, fleas and bedbugs account for most of the insects that bite their victims in search of a blood meal.
The saliva they inject can cause a reaction. This may prompt an infection, an eczema flare-up, or anaphylactic shock in the most serious cases, and these clearly warrant appropriate treatment, says DTB.
But in many cases, the reaction is mild, and a range of over the counter remedies is available to deal with the resulting itching, pain and swelling, and secondary problems caused by scratching.
Although antihistamine tablets are widely recommended to quell the itching associated with insect bites, there's not much evidence to back this up, says DTB. And none of the products used in the studies that have been done have been licensed for use in the UK.
Steroids (creams and tablets) are recommended for itching and inflammation, although there is no actual evidence to support their use, says DTB, except for people with eczema.
And DTB goes on to warn that steroid based creams should be used only sparingly and not on the face or broken skin, which typically accompanies vigorous scratching.
Similarly, although steroid tablets are recommended for severe localised and systemic reactions, there isn't any evidence to back up that approach either.
Creams containing painkillers/anaesthetics, such as lidocaine, benzocaine, or combined with antihistamines and antiseptics, are only "marginally effective and occasionally cause sensitisation," says DTB.
There is no hard evidence for the use of the anti-itch preparation Crotramiton, and the drugs bible, the British National Formulary (BNF), notes that "it is of uncertain value," says DTB.
While there is some evidence to suggest that dilute ammonium solution (counter-irritant) may help relieve itching and/or burning, there is little evidence for antiseptics or astringents.
"There is little evidence for the efficacy of treatments for simple insect bites. The symptoms are often self limiting and in many cases, no treatment may be needed," concludes DTB.
Provided by
British Medical Journal
-
No 'convincing evidence' that glitazones work better than older diabetes drugs
Apr 10, 2008 |
not rated yet |
0
-
Little or no evidence that herbal remedies relieve menopausal symptoms
Jan 14, 2009 |
not rated yet |
0
-
UK advice on sun creams 'not in the interests of public health,' warns DTB
Jun 01, 2011 |
not rated yet |
0
-
Thumbs down for new testosterone patch to boost women's sex drive
Mar 03, 2009 |
not rated yet |
0
-
Use of testosterone for 'male menopause' questionable says DTB
Jun 03, 2010 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Why is zone 1 in liver more prone to ischemic injury?
May 23, 2013
-
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013
-
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
- More from Physics Forums - Medical Sciences
More news stories
Merck ends development of Parkinson's disease drug
(AP)—Merck & Co. says it is ending development of an experimental Parkinson's disease drug because the drug wasn't working.
Medications
May 23, 2013 |
1 / 5 (1) |
0
J&J expects 10-plus new drug applications by 2017
(AP)—Johnson & Johnson is developing what could eventually be game-changing treatments for depression and pain, and it's aiming to apply for approval of more than 10 new medicines by 2017, executives said Thursday during ...
Medications
May 23, 2013 |
5 / 5 (1) |
0
Experts favor US approval of Merck sleeping pill (Update)
An independent panel of experts on Wednesday recommended US approval of a new Merck sleeping pill called suvorexant, but expressed concerns over the highest dosage and risks of drowsy daytime driving.
Medications
May 22, 2013 |
not rated yet |
0
Glaxo, US partnering to develop new antibiotics
GlaxoSmithKline PLC says it's starting an unusual collaboration with the U.S. government to develop several antibiotics for both bioterrorism threats and bacterial infections resistant to current medicines.
Medications
May 22, 2013 |
not rated yet |
0
Study finds new pneumococcal vaccine appears to be as safe as previously used vaccine
The new 13-valent pneumococcal conjugate vaccine (PCV13) appears to be as safe as the previous version used prior to 2010, the 7-valent pneumococcal conjugate vaccine (PCV7), according to a Kaiser Permanente study published ...
Medications
May 22, 2013 |
not rated yet |
0
Engineered cytomegalovirus protects monkeys from HIV equivalent
(Medical Xpress)—A new study by researchers in the US has shown that an ancient virus can be modified to help in the fight against the simian immunodeficiency virus SIV, which is the equivalent in monkeys ...
Researchers identify first drug targets in childhood genetic tumor disorder
Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...
Hormone levels may provide key to understanding psychological disorders in women
Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL.
Going live: Immune cell activation in multiple sclerosis
Biological processes are generally based on events at the molecular and cellular level. To understand what happens in the course of infections, diseases or normal bodily functions, scientists would need to ...
Driving and hands-free talking lead to spike in errors, study shows
Talking on a hands-free device while behind the wheel can lead to a sharp increase in errors that could imperil other drivers on the road, according to new research from the University of Alberta.
Help at hand for people with schizophrenia
How can healthy people who hear voices help schizophrenics? Finding the answer for this is at the centre of research conducted at the University of Bergen.